Is Cold Laser Therapy Effective? What the Science Says

Cold laser therapy, known in research literature as low-level laser therapy (LLLT) or photobiomodulation, has genuine scientific support for a handful of specific conditions, but the evidence is far from uniform. Dozens of randomized controlled trials show meaningful pain relief for neck pain, tendon injuries, and knee osteoarthritis, and the therapy has carved out a clearer role in wound healing and oral mucositis. Yet the same body of research is riddled with inconsistencies in dosing, wavelength selection, and treatment protocols, which means that a session at one clinic may bear little resemblance to one down the street. The question is less “does cold laser work at all” and more “does it work for your problem, at the right dose, delivered correctly.”

What Cold Laser Therapy Actually Does Inside the Body

Cold laser devices emit light in the red to near-infrared range, typically between about 600 and 1,100 nanometers, at power levels low enough that they do not heat tissue the way surgical lasers do. The leading explanation for how this light produces a biological effect centers on an enzyme inside mitochondria called cytochrome c oxidase. Under normal conditions, nitric oxide can bind to this enzyme and slow down cellular energy production. When red or near-infrared photons hit the enzyme, they appear to knock nitric oxide loose, restoring normal electron transport and boosting the cell’s energy output.¹ That energy boost, in turn, is thought to trigger a cascade of downstream effects: reduced inflammation, increased collagen production, and faster tissue repair.

One of the most important findings about this mechanism is that it follows a biphasic dose response. Low doses of light stimulate and repair tissue, while higher doses can actually inhibit healing or cause harm. This pattern has been confirmed both in cell studies and in animal experiments.² Researchers studying traumatic brain injury in mice, for instance, found that neurological benefits peaked at a specific energy density and then dropped off as the dose climbed higher.³ A 2024 study examining near-infrared light on red blood cells saw the same thing: protective antioxidant effects at low energy levels, but damage at higher ones, with the sweet spot falling somewhere between 60 seconds and 15 minutes of exposure.⁴ This biphasic relationship is a big deal, because it means that “more light” does not equal “better results,” and it helps explain why some clinical trials come up empty while others show clear benefits.

Where the Evidence for Pain Relief Is Strongest

Musculoskeletal pain is the condition most heavily studied in cold laser research, and the results are genuinely encouraging for several specific problems when the treatment parameters are chosen well.

Neck pain has some of the most convincing data. A systematic review and meta-analysis published in The Lancet pooled trials of chronic neck pain and found that patients receiving cold laser were about four times more likely to report pain improvement than those receiving a placebo. On a standard 100-millimeter pain scale, laser-treated patients reported roughly 20 millimeters less pain, and those gains persisted at follow-ups ranging from one to 22 weeks after treatment ended.⁵ A more recent sham-controlled trial specifically in chronic nonspecific neck pain confirmed statistically significant short-term pain reduction in the laser group.⁶

For low back pain, a meta-analysis of randomized controlled trials found significant pain reduction at immediate and short-term follow-up when at least three joules per treatment point were delivered. Patients were roughly twice as likely to report global improvement with laser compared to placebo.⁷ Those benefits were clearest in patients whose pain had lasted less than about two and a half years, hinting that earlier intervention may matter.

Knee osteoarthritis is another area with positive but not overwhelming evidence. One trial using an 830-nanometer laser on chronic knee pain concluded it was an effective treatment.⁸ A randomized double-blind trial found that cold laser combined with exercise produced meaningful improvements in pain and function that laser or exercise alone did not match.⁹ This combination effect is worth noting: in several conditions, cold laser appears to work best as part of a broader rehabilitation program rather than as a standalone fix.

Tendon Injuries and Sports Recovery

Tendinopathy, the chronic degeneration and pain in tendons, is a condition where cold laser has produced some of the most specific and reproducible results. A meta-analysis pooling data from higher-quality trials found that patients with lateral epicondylitis (tennis elbow) treated with cold laser had grip strength nearly 10 kilograms higher than control groups. In Achilles tendinopathy, laser-treated patients reported roughly 14 millimeters less pain on a 100-millimeter scale.¹⁰ A separate systematic review agreed that cold laser showed consistent results compared to placebo in tendinopathy, though the authors noted more studies were needed.¹¹

A randomized trial specifically examining recreational athletes with chronic Achilles tendinopathy offers a useful case study. Participants who received cold laser alongside eccentric exercises reported pain scores of about 33 on the 100-point scale at 12 weeks, compared to 53 in the sham group. Improvements in morning stiffness, ankle flexibility, and tenderness all favored the laser group as well.¹² These are not dramatic overnight cures, but for a notoriously stubborn condition, a roughly 20-point pain improvement on top of exercise is clinically meaningful.

Why So Many Studies Disagree

If cold laser therapy clearly helps in those trials, why do other studies find nothing? The answer almost always comes back to dose. A systematic review of acute pain trials revealed a telling pattern: seven trials that irradiated only a single skin point or delivered less than five joules total found no significant effect. But nine methodologically sound trials that treated three or more points and delivered between 5 and 19.5 joules found results favoring the laser group in 15 out of 18 outcome comparisons.¹³ In other words, underdosing is likely a major reason some trials appear to fail. Given the biphasic response described earlier, overdosing could also produce null or even negative results, but underdosing is the more common problem in the published literature.

There is also a persistent standardization issue across the field. Researchers use different wavelengths, power densities, pulse frequencies, treatment durations, and numbers of sessions. Two trials both labeled “LLLT for knee osteoarthritis” may have delivered wildly different amounts of photon energy to the target tissue. This lack of standardization is the single biggest obstacle to drawing clean conclusions, and it has plagued the field for decades. It also makes it hard for a consumer walking into a physical therapy clinic to know whether the device and protocol being used match the parameters that actually worked in trials.

Wound Healing and Diabetic Foot Ulcers

Outside pain management, wound healing is where cold laser has built a credible evidence base. Chronic diabetic foot ulcers are a major complication of diabetes, and they heal slowly because high blood sugar disrupts the normal repair process. Cold laser appears to counteract some of that disruption by promoting collagen production, attracting growth factors, and stimulating cell migration to the wound site.¹⁴

A randomized clinical trial on chronic diabetic foot wounds found that cold laser accelerated the healing process and appeared to shorten the time needed to achieve complete closure.¹⁵ A broader critical survey of the research on this topic confirmed that near-infrared irradiation can speed up wound closure, with both animal models and human data supporting faster tissue contraction and more organized collagen in laser-treated wounds.¹⁶ The evidence here is still limited in scale, but the direction is consistent and the biological rationale is solid.

Oral Mucositis in Cancer Patients

One of the more compelling clinical applications is in managing oral mucositis, the painful mouth sores that develop in many cancer patients undergoing chemotherapy or radiation to the head and neck. These sores can become severe enough to interrupt treatment, require hospitalization, and drastically reduce quality of life. Cold laser therapy has been shown to reduce both the severity of mucositis and the pain associated with it, and a recent study found it to be more effective, faster-acting, and more cost-efficient than standard care.¹⁷ A review of the broader evidence agreed that photobiomodulation is a promising treatment for oral mucositis, although the authors cautioned that safety at the tumor site still needs more rigorous study in long-term randomized trials.¹⁸ That safety caveat matters: when you are dealing with cancer, any therapy that might affect cell growth at a tumor site needs careful vetting before routine use.

Hair Regrowth for Pattern Baldness

The consumer market for cold laser is arguably loudest around hair loss, and there is real science behind the marketing. A review of randomized controlled trials found that cold laser stimulated hair growth in both men and women with androgenetic alopecia, showing statistically significant increases in terminal hair count. One study found that cold laser and minoxidil (the active ingredient in Rogaine) had similar effectiveness, and combining the two worked better than either alone.¹⁹ A 24-week randomized double-blind trial using a helmet-type laser device confirmed significant improvements in both hair density and hair diameter compared to sham, with only mild side effects like temporary shedding and scalp itching.²⁰

The regulatory landscape reflects this evidence. As of a review of the FDA’s 510(k) database, 47 low-level laser devices had received premarket clearance for treating hair loss, with the number growing steadily since 2007 and indications expanding to cover both men and women.²¹ Worth understanding, though, is that 510(k) clearance does not mean the same thing as FDA approval for a drug. It means the device has been shown to be substantially equivalent to a previously cleared device in terms of safety and intended use, and the evidence bar is considerably lower than what a pharmaceutical needs to clear. The clinical data supporting laser caps and helmets is genuinely positive, but do not mistake a cleared device for a guaranteed result. Response rates vary, and the best outcomes tend to come from consistent use over months combined with other treatments.²²

Jaw Pain and Temporomandibular Disorders

Temporomandibular disorders, the umbrella term for pain and dysfunction in the jaw joint and surrounding muscles, are another area where cold laser shows promise. A systematic review with meta-analysis found that cold laser effectively relieved pain and improved jaw function outcomes compared to placebo, with the strongest effects at short-term follow-up.²³ A larger systematic review of 34 studies found 18 showing that cold laser reduced jaw pain, though 12 found it was no better than placebo or other treatments, and four had mixed results across different outcomes.²⁴ That roughly even split probably reflects the dose standardization problem: when treatment parameters are well-chosen, laser helps; when they are not, it does not do more than placebo.

Neuropathic Pain

For nerve-related pain, the evidence is emerging but still thin. A systematic review concluded that cold laser has positive effects on neuropathic pain control, citing low cost, noninvasiveness, and rare side effects as practical advantages.²⁵ A study of patients with painful diabetic peripheral neuropathy found significant reductions in pain scores and improvements in sensory function after treatment.²⁶ These are encouraging signals, but neuropathic pain is highly heterogeneous, and the number of well-controlled trials remains small compared to the musculoskeletal literature.

How Cold Laser Compares to Other Physical Therapies

A fair question is whether cold laser actually offers anything that other, more established therapies do not. A large systematic review and meta-analysis comparing cold laser to extracorporeal shock wave therapy (ESWT) across musculoskeletal conditions found that the two were largely equivalent in terms of pain relief, strength, range of motion, and quality of life. Shock wave therapy showed a small functional edge over cold laser in some short-term measures, but the overall certainty rating suggested equivalent effects.²⁷ A randomized trial for plantar fasciitis found that cold laser and shock wave therapy both produced about a 70 percent success rate, both significantly outperforming ultrasound therapy.²⁸ So cold laser is not necessarily better than other evidence-based physical therapies, but it is roughly in the same ballpark for many conditions, with the added advantage of being painless and having very few side effects.

Lasers Versus LEDs and the Consumer Device Question

If you have shopped for a home cold laser device, you have encountered the laser-versus-LED debate. Many consumer products use LEDs rather than actual laser diodes, and some manufacturers claim this does not matter because the wavelength is the same. Others insist that only coherent laser light penetrates deeply enough to work. The reality is more nuanced. Some manufacturers promote “superpulsed” lasers with high peak power levels, claiming this enables deeper tissue penetration. While it is true that a higher power density at the skin surface does push the threshold depth slightly deeper, the key detail is that these devices pulse very briefly, so the total amount of energy actually reaching deep tissue is only a fraction of what the peak power numbers suggest.²⁹ For superficial targets like the scalp or shallow wounds, an LED at the right wavelength and power density can deliver similar biological effects. For deeper targets like joints or tendons, the penetration advantage of a focused laser beam starts to matter more. The practical takeaway for consumers is that wavelength and total energy delivered matter more than whether the source is technically a laser or an LED, but cheap, underpowered LED panels are unlikely to deliver enough energy to tissue to cross the therapeutic threshold.

Veterinary Use and What It Reveals About the Field

Cold laser has become popular in veterinary medicine, especially for arthritis and wound care in dogs and horses. Interestingly, the veterinary evidence mirrors the human evidence’s central weakness. A systematic review of veterinary laser therapy found that for most conditions, the scientific evidence for favorable clinical effects was insufficient. Studies were either negative, of low quality, contradictory, or lacked confirmation. The review pointed to the same problem seen in human research: a wide variety of treatment parameters across studies and frequent failure to even fully report the dose used.³⁰ A more recent review using text mining across both human and veterinary literature was more optimistic, noting that photobiomodulation has emerged as a non-invasive approach used to treat musculoskeletal conditions, promote wound healing, and reduce inflammation and pain in both fields.³¹ The veterinary world is useful as a reality check because placebo effects in animals, while they do exist in some forms, are far less of a concern than in human pain studies. That both positive and null results exist in animal patients reinforces the idea that cold laser genuinely does something, but only when the parameters are right.

What to Look for If You Are Considering Treatment

If you are weighing cold laser therapy for a specific problem, a few practical considerations can help you separate a credible treatment from a waste of money. First, ask about the wavelength. The strongest evidence clusters around the 630-to-900 nanometer range, with 830 nanometers and 904 nanometers appearing frequently in positive trials for musculoskeletal conditions. Second, ask about the total energy per session. Trials that delivered less than five joules total to the treatment area tended to fail. The positive acute pain trials generally delivered between 5 and 19.5 joules across multiple treatment points.¹³ Third, understand that cold laser is not a one-session solution. Most positive trials involved multiple sessions over weeks. Finally, the conditions with the strongest support are chronic neck pain, tendinopathy, chronic low back pain, oral mucositis, and androgenetic alopecia. For conditions outside those categories, the evidence is either early-stage or mixed enough that you should keep your expectations modest.

Cold laser is remarkably safe. Serious adverse events are essentially absent from the literature. The most commonly reported side effects across conditions are mild and transient: temporary redness, slight warmth at the treatment site, or in the case of hair-loss devices, temporary shedding in the first few weeks. It is not appropriate over active cancerous lesions, and eye protection is standard during treatment, but beyond those precautions, the risk profile is about as benign as any physical therapy modality gets. The real risk is not injury but rather wasted time and money on an underdosed or poorly targeted treatment that was never going to work at those parameters.